Study to Evaluate Efficacy and Safety of BGB-3111 in Participants With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Beijing Cancer Hospital, Beijing

The First Hospital of Jilin University, Changchun

Fudan University Shanghai Cancer Center, Shanghai

Jiangsu Province Hospital, Nanjing

Institute of Hematology and Hospital of Blood Disease, Tianjin

Tianjin Medical University Cancer Institute and Hospital, Tianjin

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

Fujian Medical University Union Hospital, Fuzhou

Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan

Henan Cancer Hospital, Zhengzhou

Nanfang Hospital of Southern Medical University, Guangzhou

West China Hospital, Sichuan University, Chengdu